临床前 CRO 市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00003316
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Preclinical CROs Market Trends, Size and Forecast by 2031

Buy Now

2023年临床前CRO市场规模预计为55.2亿美元,预计到2031年将达到111.9亿美元;预计到 2031 年,复合年增长率将达到 9.2%。临床试验数量的增加可能仍然是临床前 CRO 市场的关键趋势。

 

临床前 CRO 市场分析

罕见病患病率的上升以及制药公司将药物开发外包给 CRO 的活动数量不断增加,正在推动临床前 CRO 市场的增长。此外,临床前开发的改进导致成本降低,时间表也推动了临床前 CRO 市场的增长。例如,制药公司将达到 FIH 申请所需的时间缩短了 40% 或更多,药物从候选提名到开始临床试验仅需 12 至 15 个月。这样的时间表不仅使患者能够快速获得创新药物,而且还使制药公司能够通过更长的市场独占期药物来实现高收入目标。

 

临床前 CRO 市场概览

临床前 CRO 或临床前合同研究组织提供将药品或医疗器械从绘图板到分销所需的经验、知识和技能。大多数赞助组织不具备在特殊监督下进行测试所需的设施和人员,也不具备针对特定药物和医疗器械的适当设置,因此选择承包此类研究。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

临床前 CRO 市场:

临床前CRO市场
  • Preclinical CROs Market
    复合年增长率(2023 - 2031)
    9.2%
  • 2023 年市场规模
    55.2 亿美元
  • 2031年市场规模
    111.9亿美元

市场动态

增长动力
  • 加大医药研发投入
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  • 科文斯公司
  • 查尔斯河
  • 欧陆科技
  • PRA 健康科学
  • 药明康德
  • 梅德佩斯公司
  • 医药产品开发有限责任公司
  • 精锐国际公司
  • ICON 股份有限公司
  • MD 生物科学

区域概况

Preclinical CROs Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Preclinical CROs Market服务
  • 生物分析和 DMPK 研究
  • 毒理学
  • 其他服务
Preclinical CROs Market最终用户
  • 生物制药公司
  • 政府及学术机构
  • 医疗器械公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

临床前 CRO 市场驱动因素和机遇

 

对 CRO 的偏好增加  

随着临床试验变得越来越复杂,正确执行和监督研究型组织中发生的操作非常重要。为了避免因执行不当而出现错误,研究型组织正在外包临床试验来开发其产品。 CRO 通过使用高质量设施和深厚的主题专业知识提供的服务,协助临床试验的成功实施。 CRO 已开始通过其高效且具有成本效益的运营来充当临床试验行业的支柱,从而使试验申办者受益。根据 Thermo Fisher Scientific 发表的博客,2022 年,大约四分之三的临床试验是由 CRO 进行的。 CRO 不仅让药物开发商的临床项目放心,而且还提供丰富的专业知识,提高时间和成本效率,并提供定制的高质量数据。开发具有成本效益的解决方案以及减少 CRO 在药物开发过程中的错误也推动了临床前 CRO 市场的增长。

 

生物仿制药和生物制剂的兴起——临床前 CRO 市场的机遇

生物治疗是制药行业中增长最快的部门。生物治疗药物的功效和安全性与治疗各种无法治疗的疾病的能力相关,主要推动生物仿制药和生物制剂的增长。技术进步以及对癌症、类风湿性关节炎等疾病认识的显着提高正在创造对生物仿制药和生物制剂开发的需求。制药和生物制药公司主要投资于研发活动,以开发创新和先进的生物分子。公司正在利用其在生物制品制造方面的专业知识,通过满足未满足的条件来创造更多收入。近年来,生物制品许可证申请(BLA)有所增加。生物制剂是复杂的大分子,其大小高达小分子仿制药的 1,000 倍。在新的生物制药产品在美国上市之前,FDA 必须批准新药的 NDA 或生物制剂的 BLA。 FDA 批准 NDA 或 BLA 之前所需的步骤通常包括临床前研究,然后是多个阶段的临床试验。为了节省生物制剂和生物仿制药初始阶段整个开发过程中这些测试服务所需的内部成本和时间,公司更愿意将这些服务外包给临床前CRO。预计这将成为未来几年全球临床前 CRO 发展的潜在机会。

 

临床前 CRO 市场报告细分分析

有助于得出临床前 CRO 市场分析的关键部分是服务和最终用户。

  • 根据服务,临床前 CRO 市场细分为生物分析和 DMPK 研究、毒理学和其他服务。毒理学部分在 2023 年占据了最大的市场份额。
  • 按最终用户划分,临床前 CRO 市场分为生物制药公司、政府和学术机构以及医疗器械公司。 2023 年,生物制药公司细分市场占据最大市场份额。

 

按地域划分的临床前 CRO 市场份额分析

临床前 CRO 市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。

北美主导了临床前 CRO 市场。该市场的增长主要是由研发支出的增加推动的。此外,由于专利到期,各制药公司面临着利润率较低的问题,因此刺激制造商开始通过合同研究机构外包这些研究来减少内部研发活动。这使得临床前 CRO 经历了显着的增长。生物技术和制药公司为降低药物开发成本而展开的对抗预计将推动北美临床前 CRO 市场的发展。此外,孤儿和罕见疾病领域服务和药品需求的增长预计将刺激药品制造商通过 CRO 咨询专业疗法和全球站点关系,以帮助他们设计更智能的药品并招募患者进行临床试验。此外,预计亚太地区在未来几年将创下最高的复合年增长率。 

 

临床前 CRO 市场报告范围

报告属性细节
2023年市场规模55.2亿美元
2031 年市场规模111.9亿美元
全球复合年增长率(2023 - 2031)9.2%
历史数据2021-2022
预测期2024 - 2031
涵盖的领域按服务
  • 生物分析和 DMPK 研究
  • 毒理学
  • 其他服务
按最终用户
  • 生物制药公司
  • 政府及学术机构
  • 医疗器械公司
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 科文斯公司
  • 查尔斯河
  • 欧陆科技
  • PRA 健康科学
  • 药明康德
  • 梅德佩斯公司
  • 医药产品开发有限责任公司
  • 精锐国际公司
  • ICON 股份有限公司
  • MD 生物科学
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

临床前 CRO 市场新闻和最新动态

通过收集初步和二次研究后的定性和定量数据来评估临床前 CRO 市场,其中包括重要的公司出版物、协会数据和数据库。以下是医疗保健欺诈分析和策略市场发展列表:

  • 总部位于美国的全球合同研究组织 QPS 在台湾台北开设了第二家临床前研究机构。这座占地 2,793 平方英尺的设施将促进研究扩展到其他毒理学研究和新推出的药理学研究能力。 (来源:Cision US Inc,新闻稿,2022 年)

 

临床前 CRO 市场报告范围和可交付成果

“临床前 CRO 市场规模和预测(2021-2031 年)”报告对以下领域进行了详细的市场分析:

  • 范围内涵盖的所有关键细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,例如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析,涵盖主要市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者和最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..